EGFR-TKI Alone or with Concomitant Radiotherapy for Brain Metastases in Lung Adenocarcinoma Patients with EGFR Gene Mutations

被引：0
|
作者：
Chen, Yongshun [1 ]
Yang, Jing [2 ]
Li, Xue [1 ]
Hao, Daxuan [1 ]
Wu, Xiaoyuan [1 ]
Yang, Yuanyuan [1 ]
Hu, Xiaona [1 ]
He, Chunyu [1 ]
Wang, Wen [1 ]
Liu, Jinsong [1 ]
Wang, Jianhua [1 ]
机构：
[1] Zhengzhou Univ, Dept Radiat Oncol, Canc Hosp, Henan Canc Hosp, Zhengzhou 450052, Peoples R China
[2] Angang Gen Hosp, Anyang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Brain metastasis; EGFR mutation; lung adenocarcinoma; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI05.10
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [1] EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
    Dong, Kai
    Liang, Wenhua
    Zhao, Shen
    Guo, Minzhang
    He, Qihua
    Li, Caichen
    Song, Haiqing
    He, Jianxing
    Xia, Xiaojun
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) : 268 - +
  • [2] EGFR-TKI Plus Brain Radiotherapy Versus EGFR-TKI Alone in the Management of EGFR Mutated NSCLC Patients with Brain Metastases: A Meta-Analysis
    Xia, X.
    Guo, M.
    He, J.
    Liang, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S382 - S382
  • [3] Association between EGFR-TKI Resistance and Efficacy of Radiotherapy for Brain Metastases from EGFR-mutant Lung Adenocarcinoma
    Hirata, Hidenari
    Nakamura, Katsumasa
    Kunitake, Naonobu
    Shioyama, Yoshiyuki
    Sasaki, Tomonari
    Ohga, Saiji
    Nonoshita, Takeshi
    Yoshitake, Tadamasa
    Asai, Kaori
    Inoue, Kouji
    Nagashima, Akira
    Ono, Minoru
    Honda, Hiroshi
    [J]. ANTICANCER RESEARCH, 2013, 33 (04) : 1649 - 1655
  • [4] The Efficacy of First-Generation EGFR-TKI Combined With Brain Radiotherapy as the First-Line Treatment for Lung Adenocarcinoma Patients With Brain Metastases and EGFR Sensitive Mutations: A Retrospective study
    Liu, Yuting
    Wang, Juanjuan
    Wu, Jingjing
    Yang, Qifan
    Zeng, Yulan
    Wu, Di
    Tian, Chen
    Hu, Yue
    Gu, Feifei
    Li, Chang
    Zhang, Kai
    Liu, Li
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [5] Monitoring of carcinoembryonic antigen levels is predictive of EGFR mutations and efficacy of EGFR-TKI in patients with lung adenocarcinoma
    Zhang, Yanwei
    Jin, Bo
    Shao, Minhua
    Dong, Yu
    Lou, Yuqing
    Huang, Aimi
    Han, Baohui
    [J]. TUMOR BIOLOGY, 2014, 35 (05) : 4921 - 4928
  • [6] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patients
    Zhuang, W.
    Xu, C.
    Wang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [7] Usage of EGFR-TKI and WBRT in NSCLC patients with brain metastases
    Chen, Yuh-Min
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (03) : 108 - 110
  • [8] Concomitant SBRT and EGFR-TKI Versus EGFR-TKI Alone for Oligometastatic NSCLC: A Multicenter, Randomized Phase II Study
    Peng, P.
    Chen, Y.
    Han, G.
    Meng, R.
    Zhang, S.
    Liao, Z.
    Zhang, Y.
    Gong, J.
    Xiao, C.
    Liu, X.
    Zhang, P.
    Zhang, L.
    Xia, S.
    Chu, Q.
    Chen, Y.
    Zhang, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S250 - S251
  • [9] Comparing the Clinical Efficacy of TKI Alone With TKI Plus Concomitant WBRT for EGFR Mutation-Positive Lung Adenocarcinoma Patients With Brain Metastases: A Retrospective Study
    Ge, H.
    Zhu, Q.
    Sun, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S132 - S132
  • [10] Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21
    Jiang-Yong Yu
    Si-Fan Yu
    Shu-Hang Wang
    Hua Bai
    Jun Zhao
    Tong-Tong An
    Jian-Chun Duan
    Jie Wang
    [J]. 癌症, 2016, 35 (04) : 171 - 180
12345